Publications

Publications

Filter Results: (1,686) Arrow Down
Filter Results: (1,686) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 29 of 1,686 Results →

    Ryan W. Buell

    Ryan W. Buell is a Professor of Business Administration in the Technology and Operations Management Unit at Harvard Business School. He teaches View Details

    Keywords: insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry

      Christopher A. Bartlett

      Professor Christopher A. Bartlett received an economics degree from the University of Queensland, Australia (1964), and both the masters and doctorate degrees in business administration from Harvard University (1971 and 1979). 

      As a practicing manager prior... View Details

      Keywords: health care; health care; health care; health care; health care; health care

        Debora L. Spar

        Debora Spar is the Jaime and Josefina Chua Tiampo Professor of Business Administration at Harvard Business School and Senior Associate Dean for Business and Global Society. Her current research focuses on issues of gender and technology, and the interplay between... View Details

        Keywords: health care; health care; health care; health care; health care; health care; health care; health care; health care; health care

          Karim R. Lakhani

          Karim R. Lakhani is the Dorothy & Michael Hintze Professor of Business Administration at the Harvard Business School. He specializes in technology management, innovation, digital transformation and artificial... View Details

          Keywords: health care; health care; health care; health care; health care; health care; health care; health care; health care; health care
          • 09 Jul 2001
          • Research & Ideas

          Does Misery Love Companies? How Social Performance Pays Off

          micrograms of total suspended particulates per cubic meter, yet the World Health Organization establishes 90 as a maximum safe level (Berlin's level is 50). Over 25,000 square kilometers of land were deforested in Brazil each year from... View Details
          Keywords: by Joshua D. Margolis & James P. Walsh

            Joseph L. Bower

            JOSEPH L. BOWER, Donald K. David Professor Emeritus, has been a leader in general management at Harvard Business School for 51 years. He also served on the faculty of the Harvard Kennedy School during its first decade.  He has served in many administrative roles... View Details

            Keywords: insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry
            • 27 Sep 2011
            • First Look

            First Look: September 27

            healthcare spending in 2015 and 2020, especially for expenditures on prescription drugs in nominal terms and as a percentage of overall health spending. The article concludes with a discussion of the political economy of View Details
            Keywords: Sean Silverthorne
            • Web

            Publications - Faculty & Research

            "Balancing Digital Safety and Innovation." Harvard Business Review (in press). May 2025 Case Humana Commits to Value-Based Care By: V.G. Narayanan , Henry Eyring and David Lane In late 2023, CEO Bruce Broussard reviewed health View Details
            • March 2008
            • Case

            Novartis AG: Science-Based Business

            By: H. Kent Bowen and Courtney Purrington
            Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,... View Details
            Keywords: Innovation and Invention; Resource Allocation; Product Development; Partners and Partnerships; Research and Development; Science-Based Business; Pharmaceutical Industry
            Related
            • 19 Jul 2019
            • Blog Post

            Making a Broader Impact with Multiple Disciplines

            Santosh Iyer is originally from Toronto, Canada, and pursued his undergraduate and graduate degrees in Engineering Science and Biomedical Engineering from the University of Toronto.  He is currently an EC student and will graduate with... View Details
            • July 2023
            • Case

            DayTwo: Going to Market with Gut Microbiome (Abridged)

            By: Ayelet Israeli
            DayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals. After a first year of trial rollout in... View Details
            Keywords: Business Startups; AI and Machine Learning; Nutrition; Market Entry and Exit; Product Marketing; Distribution Channels
            Related
            • 18 Oct 2021
            • Blog Post

            Embracing Activism for Social Change

            In 2020, the city of Detroit logged some 7,000 calls involving mental health emergencies—a critical issue, notes Detroit Mayor Mike Duggan, who says, “When the mentally ill turn to the police for a response, the system is broken.” To fix... View Details

              George Serafeim

              George Serafeim is the Charles M. Williams Professor of Business Administration at Harvard Business School. He co-leads a Lab, within Harvard's Digital, Data, Design Institute, that focuses on organizational transformation through major shifts, including those... View Details

              Keywords: insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry; insurance industry
              • 10 Aug 2012
              • News

              Something for the weekend

              • September 2017
              • Case

              Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry

              By: Steven Rogers and Alyssa Haywoode
              Dr. William Carson, an African-American alum of Harvard University became the President and CEO of a multi billion dollar division of Otsuka, a Japan based pharmaceutical company. His ascension to this leadership position followed a thriving career in academic medicine... View Details
              Keywords: Dr. Williams Carson; Otsuka America Pharmaceutical; Harvard; Abilify; Aripiprazole; Health Testing and Trials; Globalized Firms and Management; Globalized Markets and Industries; Cross-Cultural and Cross-Border Issues; Decision Choices and Conditions; Pharmaceutical Industry; Japan
              Related
              • Web

              PhD Programs - Doctoral

              students join the Business Economics program directly from an undergraduate or master's program, others have worked in economic consulting firms or as research assistants at universities or intergovernmental organizations. The PhD program... View Details
              • 19 Dec 2023
              • Research & Ideas

              $15 Billion in Five Years: What Data Tells Us About MacKenzie Scott’s Philanthropy

              comparison group. Top causes: education and health care Between 2020 and 2022, nonprofits in the youth, philanthropy, and housing sectors represented a larger share of grantees compared with the size of those segments of charitable giving... View Details
              Keywords: by Matthew Lee, Brian Trelstad, and Ethan Tran

                Jill J. Avery

                Dr. Jill Avery is a Senior Lecturer of Business Administration and C. Roland Christensen Distinguished Management Educator in the marketing unit at Harvard Business School. She is a respected authority on branding and brand management, customer relationship... View Details

                Keywords: consumer products; arts; advertising; automobiles; retailing; fashion; hotels ＆ motels; food; beverage
                • Web

                MS/MBA Biotechnology: Life Sciences | MBA

                ethical implications of new therapeutics, and the importance of equitable access to these discoveries. It leverages the entire resources of Harvard University and works closely with the Greater Boston area, one of the largest biotech... View Details
                • 29 Jun 2022
                • Blog Post

                Harvard Business School Announces the 2022-2023 Blavatnik Fellows

                sciences. He has also worked at Huron Consulting Group and Cured, a health tech startup. Hunter has a BA in political science from DePauw University and an MBA from HBS. Matt Ross (MBA 2022) is the... View Details